Should Californians give more money for stem cell research?
By Bradley J. Fikes,
San Diego Tribune [quotes Marcy Darnovsky]
| 04. 20. 2017
Are Californians getting their money’s worth for the $3 billion they invested in stem cell science in 2004? Is there cause for optimism that major breakthrough discoveries are about to happen? What is holding back stem cell treatments from reaching patients?
These are some of the issues to be addressed Thursday in San Diego at a special stem cell meeting that’s free and open to the public.
The session is sponsored by California’s stem cell agency and UC San Diego, a major hub of stem cell research and experimental treatment.
The event is the first in a statewide outreach tour by the California Institute for Regenerative Medicine, or CIRM.
The agency is projected to run out of money in 2020 unless more money is raised from public or private sources, and the series of forums is partly meant as a way to persuade voters to further support the institute with more funding.
PUBLIC FORUM:
The free event “Stem Cell Therapies and You” is slated for noon to 1:00 p.m. at the Sanford Consortium for Regenerative Medicine...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
By Eric Schmidt, TIME | 04.16.2024
Imagine a world where everything from plastics to concrete is produced from biomass. Personalized cell and gene therapies prevent pandemics and treat previously incurable genetic diseases. Meat is lab-grown; enhanced nutrient grains are climate-resistant. This is what the future could...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
